{{Rsnum
|rsid=2058710
|Chromosome=2
|position=206257058
|Orientation=plus
|GMAF=0.2084
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=GPR1-AS
|Gene_s=GPR1-AS
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 56.6 | 38.1 | 5.3
| HCB | 63.5 | 32.1 | 4.4
| JPT | 75.9 | 22.3 | 1.8
| YRI | 87.1 | 12.9 | 0.0
| ASW | 75.4 | 22.8 | 1.8
| CHB | 63.5 | 32.1 | 4.4
| CHD | 63.3 | 32.1 | 4.6
| GIH | 70.3 | 28.7 | 1.0
| LWK | 78.2 | 21.8 | 0.0
| MEX | 48.3 | 41.4 | 10.3
| MKK | 73.7 | 24.4 | 1.9
| TSI | 54.9 | 42.2 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=A
|Pval=0.000009
|OR=1.2400
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}